Stockreport

Sierra Oncology Launches Campaign Exploring Non-Dilutive Strategic Options to Support Development of its DDR Assets

Sierra Oncology, Inc.  (SRRA) 
Last sierra oncology, inc. earnings: 3/3 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sierraoncology.com
PDF - Corporate prioritization of portfolio to focus resources on advancement of momelotinib -- Exploring non-dilutive options to support future continued development of SRA [Read more]